128 related articles for article (PubMed ID: 1798068)
1. [Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
Konaga E; Takeuchi H; Orita K; Fuchimoto S; Ogawa K; Kitagawa T; Tokuda N; Kimura H; Hamada F; Nishiyama Y
Jpn J Antibiot; 1991 Dec; 44(12):1341-50. PubMed ID: 1798068
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Matsuda S; Oh K; Tateno M; Kojima Y; Hirabayashi K; Okada E; Doko F; Kawai J
Jpn J Antibiot; 1991 Dec; 44(12):1359-67. PubMed ID: 1798070
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of intramuscular imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Chimura T; Banzai M; Yamazaki K; Miyata R; Yokoyama Y; Matsuo M; Oda T; Kihara K; Kanasugi H; Takahashi H
Jpn J Antibiot; 1991 Dec; 44(12):1351-8. PubMed ID: 1798069
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience.
Garau J; Calandra GB
Chemotherapy; 1991; 37 Suppl 2():44-52. PubMed ID: 1879187
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.
Tazuma S; Igarashi Y; Inui K; Ohara H; Tsuyuguchi T; Ryozawa S;
J Gastroenterol; 2015 Feb; 50(2):221-9. PubMed ID: 24795092
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K
Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of imipenem/cilastatin sodium in the internal medicine].
Fukuhara H; Kusano N; Nakamura H; Kaneshima H; Irabu Y; Shimozi K; Kitukawa K; Shigeno Y; Saito A; Kakazu T
Jpn J Antibiot; 1991 Aug; 44(8):877-85. PubMed ID: 1920813
[TBL] [Abstract][Full Text] [Related]
8. Twice daily intramuscular imipenem/cilastatin in the treatment of skin and soft tissue infections.
Sexton DJ; Wlodaver CG; Tobey LE; Yangco BG; Graziani AL; MacGregor RR
Chemotherapy; 1991; 37 Suppl 2():26-30. PubMed ID: 1879184
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
Naito K; Kobayashi M; Okumura M; Ikeda Y; Mitomo Y; Oguri T; Tanaka M; Ohara K; Kodera Y; Ohno R
Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
[TBL] [Abstract][Full Text] [Related]
10. Imipenem/cilastatin as secondary therapy for bacterial infections.
Kono K; Onuki K; Tohara S; Takeda S
Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular imipenem/cilastatin treatment of upper reproductive tract infection in women: efficacy and use characteristics.
McGregor JA; Christensen FB; French JI
Chemotherapy; 1991; 37 Suppl 2():31-6. PubMed ID: 1879185
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases].
Sawae Y; Niho Y; Harada M; Shibuya T; Okamura T; Asano Y; Taniguchi S; Murakawa M; Toyoshima T; Kozuru M
Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965
[TBL] [Abstract][Full Text] [Related]
13. Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation.
Kahan FM; Rogers JD
Chemotherapy; 1991; 37 Suppl 2():21-5. PubMed ID: 1879183
[TBL] [Abstract][Full Text] [Related]
14. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
Midy D; Pometan JP; Baste JC; Pajadon V
J Chir (Paris); 1992; 129(6-7):303-8. PubMed ID: 1474112
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of intramuscular imipenem/cilastatin (IPM/CS) for complicated urinary tract infections].
Shindo K; Hori T; Hayashi M; Kiyokawa S; Maeda K; Iwasaki S; Maruta N; Yamada J; Morimitsu H; Taide M; Hoshino K; Shimomae H; Matsuo R; Suzu H; Nishimura N; Hashiguchi J; Saito Y
Jpn J Antibiot; 1997 Jul; 50(7):628-39. PubMed ID: 9743908
[TBL] [Abstract][Full Text] [Related]
16. [Clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Chimura T; Banzai M; Nara N; Kawachiya S; Ogawa T; Miyata R; Yamazaki K; Aoyama S; Matsuo M; Yokoyama Y
Jpn J Antibiot; 1992 Aug; 45(8):1029-38. PubMed ID: 1433892
[TBL] [Abstract][Full Text] [Related]
17. [A clinical phase I study on intramuscular imipenem/cilastatin sodium].
Onishi A; Otawa M; Hara K
Jpn J Antibiot; 1991 Aug; 44(8):860-76. PubMed ID: 1920812
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic, bacteriological and clinical studies on imipenem/cilastatin sodium in neonates].
Iwai N; Nakamura H; Miyazu M; Kasai K; Taneda Y
Jpn J Antibiot; 1989 May; 42(5):1087-101. PubMed ID: 2746858
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and tolerance of intravenously administered imipenem/cilastatin in the treatment of septicaemia.
Linton DM; Aitchison JM; Potgieter PD
S Afr Med J; 1989 Jun; 75(11):529-31. PubMed ID: 2658141
[TBL] [Abstract][Full Text] [Related]
20. [Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections].
Takamoto M; Ishibashi T; Toyoshima H; Tanaka H; Tamaru N; Watanabe K; Yoshida M; Tokunaga N; Ichikawa Y; Oizumi K
Jpn J Antibiot; 1994 Sep; 47(9):1131-44. PubMed ID: 7990255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
